Natrilix Sr (Indapamide)

Indapamide, the active ingredient in Natrilix SR, is a thiazide-like diuretic presented as a 1.5 mg sustained‑release tablet for oral use. It treats hypertension and edema associated with heart failure or renal impairment in adult patients.

GNH USA supplies Natrilix SR as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic used to manage conditions related to fluid overload and elevated blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure, helping to reduce the risk of cardiovascular events. - Edema associated with heart failure: promotes diuresis to decrease fluid accumulation and improve symptomatic relief. - Renal impairment‑related edema: facilitates removal of excess fluid when kidney function is compromised.

Indapamide may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Electrolyte imbalance: hyponatremia, hypokalemia, or hypomagnesemia. - Increased urination: polyuria or nocturia. - Dizziness or light‑headedness, especially when standing. - Headache or mild fatigue.

Serious or Rare Side Effects: - Severe dehydration or electrolyte disturbances leading to arrhythmia. - Acute gout attacks due to elevated uric acid levels. - Allergic reactions such as rash, pruritus, or angioedema.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

- Monitor electrolytes: check serum sodium, potassium, and chloride regularly. - Assess renal function: evaluate creatinine and eGFR before and during treatment. - Caution in diabetes: monitor blood glucose as diuresis may affect glycemic control. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. - Pregnancy and lactation: use only if potential benefit justifies risk, as safety data are limited. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Indapamide can alter the pharmacodynamic or pharmacokinetic profile of several co‑administered medicines.

Major Interactions (Avoid): - Lithium: concomitant use may increase lithium concentrations, risking toxicity. - NSAIDs: may blunt the diuretic effect and worsen renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering effect; monitor for hypotension. - Beta‑blockers: enhanced antihypertensive response; observe for excessive bradycardia. - Antidiabetic agents: may potentiate hypoglycemia; adjust glucose monitoring accordingly.